Suppr超能文献

多种与免疫受体酪氨酸活化基序(ITAM)偶联的自然杀伤细胞(NK细胞)受体通过衔接蛋白1(Carma1)与B细胞淋巴瘤/白血病-10(Bcl10)/黏膜相关淋巴组织淋巴瘤易位蛋白1(Malt1)复合物结合,以激活核因子κB(NF-κB)和丝裂原活化蛋白激酶(MAPK),从而选择性地控制细胞因子的产生。

Multiple ITAM-coupled NK-cell receptors engage the Bcl10/Malt1 complex via Carma1 for NF-kappaB and MAPK activation to selectively control cytokine production.

作者信息

Gross Olaf, Grupp Christina, Steinberg Christian, Zimmermann Stephanie, Strasser Dominikus, Hannesschläger Nicole, Reindl Wolfgang, Jonsson Helena, Huo Hairong, Littman Dan R, Peschel Christian, Yokoyama Wayne M, Krug Anne, Ruland Jürgen

机构信息

III Medizinische Klinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.

出版信息

Blood. 2008 Sep 15;112(6):2421-8. doi: 10.1182/blood-2007-11-123513. Epub 2008 Jan 11.

Abstract

Natural killer (NK) cells are innate immune cells that mediate resistance against viruses and tumors. They express multiple activating receptors that couple to immunoreceptor tyrosine-based activation motif (ITAM)-containing signaling chains for downstream cell activation. Ligation of activating NK-cell receptors induces NK-cell cytotoxicity and cytokine release. How these distinct events are selectively controlled is not well defined. Here we report the identification of a specific signaling pathway that operates downstream of the ITAM-coupled NK-cell receptors NK1.1, Ly49D, Ly49H, and NKG2D. Using primary NK cells from Bcl10(-/-), Malt1(-/-), Carma1(-/-), and Card9(-/-) mice, we demonstrate a key role for Bcl10 signalosomes in the activation of canonical NF-kappaB signaling as well as JNK and p38 MAPK upon NK-cell triggering. Bcl10 directly cooperates with Malt1 and depends on Carma1 (Card11) but not on Card9 for NK-cell activation. These Bcl10-dependent cascades selectively control cytokine and chemokine production but do not affect NK-cell differentiation or killing. Thus, we identify a molecular basis for the segregation of NK-cell receptor-induced signals for cytokine release and target cell killing and extend the previously recognized roles for CARD-protein/Bcl10/Malt1 complexes in ITAM receptor signaling in innate and adaptive immune cells.

摘要

自然杀伤(NK)细胞是介导抗病毒和抗肿瘤抗性的先天性免疫细胞。它们表达多种激活受体,这些受体与含有基于免疫受体酪氨酸的激活基序(ITAM)的信号链偶联,用于下游细胞激活。激活NK细胞受体的连接诱导NK细胞的细胞毒性和细胞因子释放。这些不同事件如何被选择性控制尚不清楚。在这里,我们报告鉴定了一种在ITAM偶联的NK细胞受体NK1.1、Ly49D、Ly49H和NKG2D下游起作用的特定信号通路。使用来自Bcl10(-/-)、Malt1(-/-)、Carma1(-/-)和Card9(-/-)小鼠的原代NK细胞,我们证明了Bcl10信号体在NK细胞触发时对经典NF-κB信号通路以及JNK和p38 MAPK激活中的关键作用。Bcl10直接与Malt1合作,并且NK细胞激活依赖于Carma1(Card11)而不依赖于Card9。这些Bcl10依赖性级联选择性地控制细胞因子和趋化因子的产生,但不影响NK细胞的分化或杀伤。因此,我们确定了NK细胞受体诱导的细胞因子释放信号和靶细胞杀伤信号分离的分子基础,并扩展了先前在先天性和适应性免疫细胞中CARD蛋白/Bcl10/Malt1复合物在ITAM受体信号传导中的作用。

相似文献

2
Cell type-specific regulation of ITAM-mediated NF-kappaB activation by the adaptors, CARMA1 and CARD9.
J Immunol. 2008 Jul 15;181(2):918-30. doi: 10.4049/jimmunol.181.2.918.
3
Lymphomagenic CARD11/BCL10/MALT1 signaling drives malignant B-cell proliferation via cooperative NF-κB and JNK activation.
Proc Natl Acad Sci U S A. 2015 Dec 29;112(52):E7230-8. doi: 10.1073/pnas.1507459112. Epub 2015 Dec 14.
4
Thrombin-dependent NF-{kappa}B activation and monocyte/endothelial adhesion are mediated by the CARMA3·Bcl10·MALT1 signalosome.
J Biol Chem. 2010 Dec 31;285(53):41432-42. doi: 10.1074/jbc.M110.158949. Epub 2010 Nov 1.
5
Role of the CARMA1/BCL10/MALT1 complex in lymphoid malignancies.
Curr Opin Hematol. 2016 Jul;23(4):402-9. doi: 10.1097/MOH.0000000000000257.
10
Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells.
J Exp Med. 2009 Oct 26;206(11):2313-20. doi: 10.1084/jem.20091167. Epub 2009 Oct 19.

引用本文的文献

2
From syndromic clues to diagnosis: understanding CARD11-driven disorders.
Front Immunol. 2025 Jun 23;16:1626065. doi: 10.3389/fimmu.2025.1626065. eCollection 2025.
3
NF-κB in inflammation and cancer.
Cell Mol Immunol. 2025 Jun 25. doi: 10.1038/s41423-025-01310-w.
5
Inhibition of the MALT1-LPCAT3 axis protects cartilage degeneration and osteoarthritis.
Cell Commun Signal. 2024 Mar 22;22(1):189. doi: 10.1186/s12964-024-01547-4.
7
Inherited Human BCL10 Deficiencies.
J Clin Immunol. 2023 Dec 22;44(1):13. doi: 10.1007/s10875-023-01619-z.
8
KLF5‑mediated expression of CARD11 promotes the progression of gastric cancer.
Exp Ther Med. 2023 Jul 17;26(3):422. doi: 10.3892/etm.2023.12121. eCollection 2023 Sep.
10
Improves the Efficacy of Anti-PD1 Immunotherapy in Melanoma via l-Serine-Mediated NK Cell Activation.
Research (Wash D C). 2023 Apr 28;6:0127. doi: 10.34133/research.0127. eCollection 2023.

本文引用的文献

1
Bcl10 plays a divergent role in NK cell-mediated cytotoxicity and cytokine generation.
J Immunol. 2007 Sep 15;179(6):3752-62. doi: 10.4049/jimmunol.179.6.3752.
4
CARD-Bcl10-Malt1 signalosomes: missing link to NF-kappaB.
Sci STKE. 2007 May 1;2007(384):pe21. doi: 10.1126/stke.3842007pe21.
6
The CARMA1-Bcl10 signaling complex selectively regulates JNK2 kinase in the T cell receptor-signaling pathway.
Immunity. 2007 Jan;26(1):55-66. doi: 10.1016/j.immuni.2006.11.008. Epub 2006 Dec 28.
8
Regulation of natural killer cell activity.
Curr Opin Immunol. 2007 Feb;19(1):46-54. doi: 10.1016/j.coi.2006.11.012. Epub 2006 Dec 4.
9
CARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells.
Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):139-44. doi: 10.1073/pnas.0601947103. Epub 2006 Nov 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验